From: Effect of a vitamin/mineral supplement on children and adults with autism
 |  | Neuro-typicals (n = 44) | Arizona Treatment Group (n = 18) | Arizona Placebo Group (n = 22) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  | Pre | Post | % change | p-value | Pre | Post | % change | p-value |
Free Sulfate (plasma) | umol/ g-protein | 4.09 +/- 2.3 | 1.60 +/- 0.6 | 2.93 +/- 2.0 | +83% | 0.008 | 1.30 +/- 0.4 | 1.98 +/- 1.8 | +52% | 0.08 |
Total Sulfate (plasma) | umol/ g-protein | 1566 +/- 384 | 1150 +/- 254 | 1346 +/- 236 | +17% | 0.001 | 1093 +/- 184 | 1163 +/- 194 | +6% | 0.06 |
SAM (RBC) | umol/dl | 228.4 +/- 12 | 218 +/- 17 | 230 +/- 16 | +6% | 0.003 | 213 +/- 12 | 218 +/- 13 | +3% | 0.005 |
SAH (RBC) | umol/dl | 42.6 +/- 4.4 | 40.7 +/- 7.4 | 41.4 +/- 5.0 | +2% | n.s. | 48.5 +/- 6.9 | 45.4 +/- 7.1 | -6% | 0.03 |
Uridine (plasma) | 10-6 M | 7.9 +/- 2.7 | 16.2 +/- 9.5 | 10.4 +/- 4.7 | -36% | 0.008 | 16.4 +/- 6.9 | 14.5 +/- 5.8 | -11% | 0.06 |
Adenosine (plasma) | 10-8 M | 20.6 +/- 3.4 | 21.2 +/- 5.3 | 21.0 +/- 3.2 | -1% | n.s. | 24.5 +/- 6.2 | 22.8 +/- 4.2 | -7% | 0.05 |
Inosine (plasma) | 10-6 M | 3.83 +/- 0.9 | 3.49 +/- 1.0 | 3.83 +/- 0.6 | +10% | 0.07 | 3.55 +/- 0.9 | 3.49 +/- 1.0 | -2% | n.s. |
Reduced plasma glutathione (GSH) | nmol/ml | 4.09 +/- 0.79 | 3.27 +/- 0.59 | 3.84 +/- 0.61 | +17% | 0.0008 | 3.25 +/- 0.38 | 3.40 +/- 0.42 | +5% | n.s. |
Oxidized glutathione (GSSG) | nmol/ml | 0.362 +/- 0.10 | 0.467 +/- 0.12 | 0.403 +/- 0.09 | -14% | 0.02 | 0.465 +/- 0.14 | 0.431 +/- 0.11 | -7% | n.s. |
Ratio of oxidized to reduced plasma glutathione | Â | 0.093 +/- 0.04 | 0.150 +/- 0.05 | 0.109 +/- 0.03 | -27% | 0.002 | 0.147 +/- 0.05 | 0.132 +/- 0.05 | -10% | n.s. |
Plasma nitro-tyrosine | ug/l | 7.4 +/- 5.1 | 14.1 +/- 6.5 | 9.9 +/- 5.4 | -29% | 0.004 | 19.0 +/0 8.6 | 16.3 +/- 9.2 | -14% | 0.10 |